[Wilson disease]

Area of Science:

• Genetics
• Metabolic Disorders
• Neuroscience

Background:

• Wilson disease is a rare inherited disorder impacting copper metabolism.
• Mutations in the ATP7B gene, crucial for copper transport in the liver and brain, underlie the disease.
• Clinical presentations are diverse, encompassing hepatic, neurological, and psychiatric symptoms.

Purpose of the Study:

• To summarize the key aspects of Wilson disease, including its genetic basis, clinical manifestations, diagnosis, and treatment.
• To highlight the importance of early intervention in managing Wilson disease.

Main Methods:

• Review of existing literature on Wilson disease.
• Analysis of clinical, biochemical, and molecular diagnostic markers.
• Evaluation of treatment strategies, including chelating agents and zinc salts.

Main Results:

• The genetic defect involves mutations in the ATP7B gene.
• Symptoms vary widely and can affect the liver, brain, and psychiatric health.
• Diagnosis relies on a combination of clinical, biochemical, and molecular findings.
• Treatment is most effective when initiated early or presymptomatically.

Conclusions:

• Wilson disease is a treatable genetic disorder of copper metabolism.
• Timely diagnosis and intervention are essential for favorable outcomes.
• Effective management involves chelating agents and zinc salts, particularly in presymptomatic individuals.